Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,

Slides:



Advertisements
Similar presentations
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
Advertisements

Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive- Compulsive Disorder  Xian-Zhang Hu, Robert H. Lipsky, Guanshan Zhu,
Volume 130, Issue 3, Pages (March 2006)
Characterization of the Human Platelet/Endothelial Cell Adhesion Molecule-1 Promoter: Identification of a GATA-2 Binding Element Required for Optimal Transcriptional.
Crucial Roles of MZF1 and Sp1 in the Transcriptional Regulation of the Peptidylarginine Deiminase Type I Gene (PADI1) in Human Keratinocytes  Sijun Dong,
by Hong Hao, Huiling Qi, and Manohar Ratnam
Volume 138, Issue 1, Pages e3 (January 2010)
Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide  Bin Li, M.S., Ming.
Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ  Claus Johansen, Trine.
Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue.
Volume 129, Issue 5, Pages (November 2005)
Volume 132, Issue 1, Pages (January 2007)
The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation  Rixun Fang, Nilda A. Santiago, Lynne C. Olds,
Zara E Khan, Timothy C Wang, Guanglin Cui, Alfred L Chi, Rod Dimaline 
Substance P Enhances the Production of Interferon-induced Protein of 10 kDa by Human Keratinocytes in Synergy with Interferon-γ  Naoko Kanda, Shinichi.
Volume 135, Issue 1, Pages (July 2008)
Recruitment of Ataxia-Telangiectasia Mutated to the p21waf1 Promoter by ZBP-89 Plays a Role in Mucosal Protection  Longchuan Bai, John Y. Kao, David J.
Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive- Compulsive Disorder  Xian-Zhang Hu, Robert H. Lipsky, Guanshan Zhu,
Volume 136, Issue 5, Pages (May 2009)
Volume 135, Issue 5, Pages e3 (November 2008)
Volume 138, Issue 1, Pages e3 (January 2010)
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Volume 116, Issue 6, Pages (June 1999)
Volume 68, Issue 3, Pages (September 2005)
Jason Park, Stephanie Schulz, Scott A. Waldman  Gastroenterology 
Qiujie Jiang, Yasushi Matsuzaki, Kehua Li, Jouni Uitto 
Volume 124, Issue 4, Pages (April 2003)
Transcriptional Control of the Mouse Col7a1 Gene in Keratinocytes: Basal and Transforming Growth Factor-β Regulated Expression  Michael Naso, Jouni Uitto,
Volume 122, Issue 7, Pages (June 2002)
Volume 75, Issue 12, Pages (June 2009)
Volume 130, Issue 3, Pages (March 2006)
Regulation of CSF1 Promoter by the SWI/SNF-like BAF Complex
Yin-Yang 1 Negatively Regulates the Differentiation-Specific Transcription of Mouse Loricrin Gene in Undifferentiated Keratinocytes  Xuezhu Xu, Yasuhiro.
17β-Estradiol Inhibits MCP-1 Production in Human Keratinocytes
Role of Sp1 in Transcription of Human ATP2A2 Gene in Keratinocytes
Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3  Shu-Jen Chen, Weihua Yuan, Yasuji Mori, Anait.
Volume 62, Issue 3, Pages (September 2002)
Volume 60, Issue 3, Pages (September 2001)
Volume 57, Issue 5, Pages (May 2000)
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  Hiroshi Kawada,
Histamine Enhances the Production of Granulocyte-Macrophage Colony-Stimulating Factor via Protein Kinase Cα and Extracellular Signal-Regulated Kinase.
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431 
Ketoconazole Suppresses Prostaglandin E2-Induced Cyclooxygenase-2 Expression in Human Epidermoid Carcinoma A-431 Cells  Naoko Kanda, Dr., Shinichi Watanabe 
Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells  S. Chen, K. Olsen, C. Grigsby, D.G.
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 13, Issue 3, Pages (March 2006)
The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation
17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
Volume 126, Issue 7, Pages (June 2004)
Romain Debret, Richard R
Volume 61, Issue 6, Pages (June 2002)
Regulation of the Melanoma Cell Adhesion Molecule Gene in Melanoma: Modulation of mRNA Synthesis by Cyclic Adenosine Monophosphate, Phorbol Ester, and.
Regulation of the Expression of Peptidylarginine Deiminase Type II Gene (PADI2) in Human Keratinocytes Involves Sp1 and Sp3 Transcription Factors  Sijun.
Volume 127, Issue 4, Pages (October 2004)
Volume 128, Issue 7, Pages (June 2005)
IFN-γ Represses IL-4 Expression via IRF-1 and IRF-2
Defining the Regulatory Elements in the Proximal Promoter of ΔNp63 in Keratinocytes: Potential Roles for Sp1/Sp3, NF-Y, and p63  Rose-Anne Romano, Barbara.
TNF Regulates the In Vivo Occupancy of Both Distal and Proximal Regulatory Regions of the MCP-1/JE Gene  Dongsheng Ping, Peter L. Jones, Jeremy M. Boss 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation. Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation.
Bart A. Jessen, Marjorie A. Phillips, Robert H. Rice 
Endogenous GATA Factors Bind the Core Sequence of the tetO and Influence Gene Regulation with the Tetracycline System  David J. Gould, Yuti Chernajovsky 
Volume 72, Issue 2, Pages (July 2007)
Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Recruitment of Ataxia-Telangiectasia Mutated to the p21waf1 Promoter by ZBP-89 Plays a Role in Mucosal Protection  Longchuan Bai, John Y. Kao, David J.
Volume 16, Issue 5, Pages (December 2004)
Stéphane Karlen, Lasse R. Braathen 
Presentation transcript:

Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi, Fayez K. Ghishan  Gastroenterology  Volume 134, Issue 7, Pages 1994-2003 (June 2008) DOI: 10.1053/j.gastro.2008.02.076 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Glucose increases expression levels of VGLUT2 mRNA and protein in MIN6 cells. (A) mRNA prepared from MIN6 cells grown in different concentrations of glucose medium for 12 hours was used for first-strand cDNA synthesis. Semiquantitative RT-PCR was performed with VGLUT2 or β-actin–specific primers in separate reactions. (B) Vesicular protein purified from MIN6 cells grown in different concentrations of glucose medium as shown for 12 hours was used for Western blot with VGLUT2 or β-actin–specific antibody. Gastroenterology 2008 134, 1994-2003DOI: (10.1053/j.gastro.2008.02.076) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Cloning and functional characterization of mVGLUT2 promoter and its regulation by glucose. (A) mVGLUT2 upstream genomic sequence and putative transcription factor binding sites. The sequence of the 1010-bp genomic region immediately upstream of the mVGLUT2 transcription start site is shown. The transcription start site is marked as +1. Putative cis-elements are underlined. PE primer is the primer used for primer extension. (B) Identification of the transcription start site of mVGLUT2. The arrow indicates the primer extension product aligned with an adenosine “A” residue as determined by comparison with the sequencing ladder. (C) Identification of the minimal mouse VGLUT2 promoter by deletion analysis. Promoter activity was measured by fold increase over the control promoterless pGL3-basic vector. (D) Glucose regulation of mVGLUT2 promoter. MIN6 cells expressing the minimal mVGLUT2 promoter were cultured in medium containing different glucose concentration as indicated. Promoter activity was measured by fold increase over the control promoterless pGL3-basic vector. □, pGL3-basic; ■, mVGLUT2 promoter. Gastroenterology 2008 134, 1994-2003DOI: (10.1053/j.gastro.2008.02.076) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Sp1 mediates basal regulation of mVGLUT2 promoter. (A) Putative consensus binding sites for transcriptional factors are indicated in the minimal functional promoter region (−96 to +68). The transcription start site is marked by box. (B) Relative luciferase activities of single mutations for Sp1 and GATA3 of mVGLUT2 promoter were measured in MIN6 cells. Values are means ± SD of duplicate data from 3 experiments. *P < .001 vs wild-type promoter constructs. (C) Electrophoretic mobility shift assay with purified MIN6 nuclear extract. The DNA-protein binding was performed with digoxigeninin-labeled wild-type or mutant oligonucleotides corresponding to the nucleotide sequence −41 to −9 of the mVGLUT2 promoter. Competition for binding was performed by including a 125-fold molar excess of unlabeled probe. Identification of the DNA-protein complex was characterized by supershift analysis with 2 specific antibodies (Ab1 and Ab2). (D) The in vivo interaction of Sp1 and mVGLUT2 promoter was evaluated by ChIP assays with the basal promoter DNA (−241/+7) and the control DNA (−722/−452) in MIN6 cells treated with different glucose concentrations. The ChIP assays were repeated 3 times on independent MIN-6 preparations. (E) Sodium dodecyl sulfate–polyacrylamide gel electrophoresis indicating equal protein loading used for ChIP assay. Gastroenterology 2008 134, 1994-2003DOI: (10.1053/j.gastro.2008.02.076) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 Role of Sp1 in glucose-induced transcription of mVGLUT2. (A) Inhibition of mVGLUT2 mRNA expression by Sp1-specific inhibitor mithramycin A. MIN6 cells cultured in a high-glucose–containing medium (25 mmol/L) were treated with or without 100 nmol/L mithramycin A for 24 hours before harvest. (B) Effects of Sp1 siRNA on mVGLUT2 promoter activity. (C) Inhibition of mVGLUT2 mRNA expression by Sp1 siRNA. Scramble (control) or Sp1 siRNA was transfected for 48 hours before next transfection with mVGLUT2 promoter. Results are means ± SE from 3 separate experiments. *P < .05. (D) Inhibition of mVGLUT2 protein expression by Sp1 siRNA. (E) Down-regulation of Sp1 protein by Sp1-specific siRNA in MIN6 cells. Western blots were performed with Sp1 or Sp3 antibody and MIN6 cells were transfected with control or Sp1-specific siRNA. Sp1 protein in MIN6 cells was inhibited by 90% by Sp1-specific siRNA whereas Sp3 protein was not affected. (F) Effects of Sp1 on mVGLUT2 transcription in Drosophila SL2 cells. One microgram of mVGLUT2 promoter construct (−96/+68) or promoterless construct (pGL3-basic) was cotransfected with 0.5 μg of Drosophila Sp1 expression vectors, pPAC/Sp1, or the blank pPAC vector. Gastroenterology 2008 134, 1994-2003DOI: (10.1053/j.gastro.2008.02.076) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 Glucose stimulates phosphorylation of Sp1 and results in an increase of Sp1 binding to mVGLUT2 promoter. (A) Glucose stimulates Sp1 phosphorylation. Nuclear protein was purified from MIN6 cells cultured in a medium containing indicated glucose concentrations for 48 hours. Western blot was performed with antibodies for Sp1 (sp1) or phosphorylated Sp1 (p-sp1). (B) Phosphorylation of Sp1 increases its binding activity to mVGLUT2 promoter. Electrophoretic mobility shift assay was performed with nuclear extract of MIN6 cells treated with protein kinase A (pka), MAPK, or protein phosphatase 1 (pp1) and DIG-labeled oligonucleotides corresponding to the nucleotide sequence −41 to −9 of the mVGLUT2 promoter. (C) Glucose activation of MAPK P-38. Western blot was performed with nuclear protein from MIN6 treated with different glucose concentrations and antibodies against P-38 (p-38) or phosphorylated P-38 (pp-38). (D) Glucose activation of MAPK P-44/42. Western blot was performed with nuclear protein from MIN6 treated with different glucose concentrations and antibodies against P-44/42 (P-44/42) or phosphorylated P-44/42 (pP-44/42). Gastroenterology 2008 134, 1994-2003DOI: (10.1053/j.gastro.2008.02.076) Copyright © 2008 AGA Institute Terms and Conditions

Figure 6 Inhibition of Sp1 phosphorylation reduces glucose-induced mVGLUT2 expression. (A) MAPK P38 inhibitor SB203580 decreases Sp1 phosphorylation and mVGLUT2 expression in MIN6 cells with dose dependence. Expression of mVGLUT2, Sp1, and phosphorylated Sp1 were detected by Western blot using specific antibodies. (B) mRNA of mVGLUT2 in MIN6 cells treated with P38 inhibitor SB203580 was detected by RT-PCR with mVGLUT2-specific primers. (C) Dual luciferase assay was measured in MIN6 cells expressing mVGLUT2 promoter (−96/+68) and treated with P38 inhibitor, SB203580, or the control agent (SB202474) for 24 hours (*P < .01). (D) MAPK P44/42 inhibitor U0126 decreases Sp1 phosphorylation and mVGLUT2 expression in MIN6 cells with dose dependence. Expression of mVGLUT2, Sp1, and phosphorylated Sp1 were detected by Western blot using specific antibodies. (E) mRNA of mVGLUT2 in MIN6 cells treated with P44/42 inhibitor U0126 was detected by RT-PCR with mVGLUT2-specific primers. (F) Dual luciferase assay was measured in MIN6 cells expressing mVGLUT2 promoter (−96/+68) and treated with P344/42 inhibitor, U0126, or the control agent (U0124) for 24 hours (*P < .01). Gastroenterology 2008 134, 1994-2003DOI: (10.1053/j.gastro.2008.02.076) Copyright © 2008 AGA Institute Terms and Conditions